Claims
- 1. A process for the manufacture of a 2-carboxypyrazine 4-oxide having the formula (I): ##STR5## wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different, and represent a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms, by oxidation of the corresponding 2-carboxypyrazine having the formula (II): ##STR6## characterized in that a carboxypyrazine (II) is reacted under stirring with an aqueous solution of H.sub.2 O.sub.2 at a pH between 0.5 and 5, in the presence of a catalyst selected from the group consisting of tungstic acid, an isopolytungstic acid, arsenotungstic acid, borotungstic acid, molybdic acid, an isopolymolybdic acid, phosphomolybdic and arsenomolybdic acid, and alkali metal salts thereof.
- 2. The process according to claim 1, wherein the temperature is between 0.degree. and 100.degree. C.
- 3. The process according to claim 2, wherein the temperature is substantially between 60.degree. C. and 90.degree. C.
- 4. The process according to claim 1, wherein one of R.sub.1, R.sub.2 and R.sub.3 is an alkyl group having from 1 to 6 carbon atoms, and the two remaining are hydrogen atoms.
- 5. The process according to claim 4, wherein the alkyl group having from 1 to 6 carbon atoms is a methyl group.
- 6. The process according to claim 1, wherein the catalyst is selected from the group consisting of tungstic acid, isopolytungstic acid, arsenotungstic acid, borotungstic acid, and alkali metal salts thereof.
- 7. The process according to claim 6, wherein the catalyst is tungstic acid or an alkali metal salt thereof.
- 8. The process according to claim 1, wherein the pH is substantially between 1.0 and 2.0.
- 9. The process according to claim 1, wherein the molar ratio between the catalyst, calculated as W or Mo, and the carboxypyrazine (II) ranges between 0.01 and 1.
- 10. The process according to claim 9, wherein said molar ratio ranges between 0.01 and 0.05.
- 11. The process according to claim 1, wherein the molar ratio between the H.sub.2 O.sub.2 and the 2-carboxypyrazine (II) ranges between 1.0 and 1.3.
- 12. The process according to claim 1, wherein the H.sub.2 O.sub.2 starting concentration in the aqueous solution ranges between 1 and 20% by weight.
- 13. The process according to claim 12, wherein said H.sub.2 O.sub.2 substantially ranges between 5% and 10% by weight.
Priority Claims (1)
Number |
Date |
Country |
Kind |
20780 A/85 |
May 1985 |
ITX |
|
CROSS REFERENCE TO RELATED APPLICATION
This application is a continuation-in-part of Ser. No. 863,425, filed May 15, 1986 abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3702831 |
Chiavellier et al. |
Nov 1972 |
|
4002750 |
Ambrogi et al. |
Jan 1977 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
0201934 |
Nov 1986 |
EPX |
Non-Patent Literature Citations (2)
Entry |
Kobayashi et al., Chem. Pharm. Bull. 22(9), 2097-2100, (1974). |
Nagy, et al., Chem. Abstracts, vol. 100 (1984), entry 51464v. |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
863425 |
May 1986 |
|